版本:
中国

BRIEF-Sanofi receives FDA approval of Thymoglobulin for prevention of acute kidney transplant rejection

April 24 Sanofi SA:

* Sanofi receives FDA approval of Thymoglobulin® for the prevention of acute kidney transplant rejection

* Sanofi- FDA approved thymoglobulin for use in conjunction with concomitant immunosuppression in prophylaxis of acute rejection in patients receiving kidney transplant Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐